NXT Nutritionals to host ‘Spring for a Cure’ for Type 1 diabetes
HOLYOKE, Mass. NXT Nutritionals Holdings, a developer and marketer of natural sweeteners, food and beverage products, on Thursday announced that former NBA Rookie of the Year, Ralph Lee Sampson, Jr., will be making a personal appearance on behalf of NXT at the Juvenile Diabetes Research Foundation International’s “Spring for a Cure” event April 30.
“We are excited to have [Sampson] join us at the Spring for a Cure event next week,” stated Mike McCarthy, president and CEO of NXT Nutritionals. “He has been actively supporting the research and the fight for a cure for diabetes, especially since hitting close to home with one of his daughters having the disease. We want to thank him for taking this opportunity to help us educate those attending the event about our Susta Natural Sweetener.”
The “Spring for a Cure” event, of which NXT is a sponsor, is a culinary, wine and spirits tasting event featuring fine cuisine and signature products from some New York restaurants.
The event is dedicated to raising money and awareness for Type 1, or juvenile diabetes.
Chill International launches cooling towel for hot flashes, night sweats
KEY WEST, Fla. Chill International on Thursday announced the launch of a new menopausal cooling towel, called Chill Cooling Towels, which provides relief for hot flashes and night sweats.
The Chill Towels were first introduced in many Walgreens in Florida this spring, the company reported.
“Initial consumer response has been overwhelming,” stated Allan Wimer, Chill CEO. “Consumers love the fact that the towels do not need to be chilled and are genuinely amazed at how long the towel’s cooling sensation lasts,” he said. “In fact, consumer tests indicate the cooling sensation lasts up to 2-3 hours depending on climate conditions.”
The towels are available in three sizes.
FDA to expand Plan B availability to 17-year-olds
ROCKVILLE, Md. The Food and Drug Administration on Wednesday informed Duramed Research, manufacturer of Plan B, that it may market the emergency contraceptive without a prescription to women age 17 years and older, following submission and approval of the appropriate application.
Currently, the emergency contraceptive Plan B is available behind the pharmacy counter for women over the age of 18, but as a prescription-only product for women 17 years old and younger.
The FDA decision came within the 30 days mandated by a federal court to permit the Plan B drug sponsor to make Plan B available to women 17 and older without a prescription.
“The government will not appeal this decision,” the FDA stated. “In accordance with the court’s order, and consistent with the scientific findings made in 2005 by the Center for Drug Evaluation and Research, FDA notified the manufacturer of Plan B informing the company that it may … market Plan B without a prescription to women 17 years of age and older.”
Plan B is manufactured by Duramed Research, which was acquired by Teva Pharmaceutical Industries in December as part of its acquisition of Barr Pharmaceuticals.